NEW DELHI- India’s Fast Track Immigration – Trusted Traveller Programme has been expanded to five more airports: Lucknow, Thiruvananthapuram, Trichy, Kozhikode, and Amritsar. Union Home Minister Amit ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. Damian Garde is a reporter at ...
Speaker Mike Johnson (R-La.) told House Republicans he wants to utilize a special fast-track process that will require cooperation from Democrats to swiftly pass the funding package that the Senate is ...
Add Yahoo as a preferred source to see more of our stories on Google. Speaker Mike Johnson (R-La.) told House Republicans he wants to utilize a special fast-track process that will require cooperation ...
French President Emmanuel Macron says he wants his government to fast-track the legal process to ensure that a ban on social media for children under the age of 15 can enter into force in September at ...
A leader’s potential is often shaped by the choices they made long before they stepped into their role. The most effective leaders seek experiences that stretch their thinking, build influence and ...
The FDA has granted Regenerative Medicine Advanced Therapy designation to NouvNeu001, a cell therapy for Parkinson’s disease. NouvNeu001, developed by iRegene, is the first allogeneic cell therapy ...
Novartis received breakthrough therapy designation from the FDA for ianalumab, a monoclonal antibody aimed at treating Sjögren’s disease. Ianalumab works by depleting B cells and blocking BAFF-R ...
The U.S. Food and Drug Administration (FDA) reportedly delayed reviews of several drugs selected for the Trump administration’s new fast-track approval program, after agency scientists raised concerns ...
Please provide your email address to receive an email when new articles are posted on . CTx001 is an investigational adeno-associated virus-based therapy for geographic atrophy. Patient dosing in the ...
Axsome Therapeutics shares rose Wednesday morning after the Food and Drug Administration gave its Alzheimer's disease drug priority review designation and supported its application for its narcolepsy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results